IOVANCE BIOTHERAPEUTICS, INC. (22) | Human Resources (10)

Browse by Subcategory

Recent Contracts

Executive Employment Agreement, effective as of December 14, 2020, by and between Jean-Marc Bellemin and Iovance Biotherapeutics, Inc (Filed With SEC on February 25, 2021)
Severance Agreement and General Release, effective July 8, 2020, between Iovance Biotherapeutics, Inc. and Timothy Morris (Filed With SEC on August 6, 2020)
Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on June 9, 2020)
Form of Incentive Stock Option Agreement under the Genesis Biopharma Inc. 2011 Equity Incentive Plan (Filed With SEC on February 25, 2020)
Form of Non-Qualified Stock Option Agreement under the Genesis Biopharma Inc. 2011 Equity Incentive Plan (Filed With SEC on February 25, 2020)
Form of Incentive Stock Option Agreement under the Lion Biotechnologies, Inc. 2014 Equity Incentive Plan (Filed With SEC on February 25, 2020)
Form of Non-Qualified Stock Option Agreement under the Lion Biotechnologies, Inc. 2014 Equity Incentive Plan (Filed With SEC on February 25, 2020)
Form of Incentive Stock Option Agreement under the Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on February 25, 2020)
Form of Non-Qualified Stock Option Agreement under the Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on February 25, 2020)
Executive Employment Agreement effective as of July 18, 2019, by and between Friedrich-Reinhard Graf Finck von Finckenstein, M.D (Filed With SEC on August 1, 2019)